News Search by Category
Below you will find all news articles for Corporate Announcements. Please click on the title to view the article in full.
20/11/2014 | A secretive German investment fund has snapped up the cosmetic surgery provider at the centre of a controversy over PIP breast implants involving thousands of British women. Sky News has learned that the owners of Transform Cosmetic Surgery Group agreed a sale earlier this week to Aurelius Investments.
17/11/2014 | Actavis plc and Allergan, Inc. announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transaction is valued at approximately $66 billion, or $219 per Allergan share.
25/09/2014 | Research unveiled today at the Annual Scientific Meeting of the British Association of Aesthetic Plastic Surgeons shows that despite a rise of 8,000% in cosmetic surgery reporting in the mainstream media over the last twenty years, many products and techniques promoted directly to the press and public actually have very few, if any, published scientific articles behind them.
08/09/2014 | Cynosure, Inc., a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has acquired the assets of Ellman International, Inc. (Pelleve®, PelleFirm™) for approximately $13.2 million in cash. In addition, Cynosure assumed certain contractual and current liabilities associated with normal working capital. Based in Hicksville, NY, Ellman develops, manufactures and markets advanced radiofrequency (RF) technology for precision surgical and aesthetic procedures and offers a line of aesthetic lasers.
08/09/2014 | ALPHAEON® Corporation, a leader in lifestyle healthcare and subsidiary of Strathspey Crown Holdings LLC, and Clarion Medical Technologies® Inc. today announced that they have entered into a definitive agreement for ALPHAEON to acquire all of the outstanding shares and assets of Clarion, the leading provider of medical and aesthetic equipment and consumables in Canada, for an undisclosed sum. The acquisition is expected to close on or before September 30, 2014.
27/08/2014 | The Aesthetic Surgery Journal (ASJ), a peer-reviewed international journal focusing on scientific developments and clinical techniques in aesthetic surgery, was recently ranked the number one journal in aesthetic plastic surgery and second in plastic surgery overall, with an Impact Factor of 2.034 according to the 2014 Thomson Reuters Journal Citation Reports®. ASJ is the official publication of the American Society for Aesthetic Plastic Surgery
11/08/2014 | The number of beauty businesses in the UK has risen by over a fifth in the last four years, according to new data from Barclays Business. Barclays has seen a 21 per cent increase in the number of small beauty businesses since 2010, in addition to a 24 per cent rise in the combined turnover of these businesses over the same time period. The proliferation of businesses in the beauty industry, which include beauty salons, hairdressers and tanning parlours, contributes £4bn to the UK economy.
27/06/2014 | Merz and Ulthera, Inc. announced that they have entered a definitive merger agreement, pursuant to which Merz will acquire global medical device company Ulthera, a deal which will accelerate Merz’s growth in the aesthetics area and expand the company’s portfolio of treatment options in facial aesthetics. Valued at up to $600 million in upfront cash and milestone payments, the acquisition is the largest in Merz’s history.
18/06/2014 | Canadian drug maker Valeant Pharmaceuticals Inc., plans to take its $53-billion offer for Allergan Inc. directly to the shareholders this week, after the Botox maker repeatedly rejected Valeant`s acquisition proposals. In the latest development of the takeover battle, Valeant`s Chief Executive Michael Pearson, in a conference call on Tuesday, said the company will take the tender offer directly to the shareholders.
10/06/2014 | Allergan Inc. (AGN), the maker of the Botox wrinkle treatment, rejected an increased bid of about $54 billion from Valeant Pharmaceuticals International Inc. (VRX) and investor Bill Ackman, calling it undervalued. Allergan turned down the offer of $72 a share in cash and 0.83 a share of Valeant stock, the Irvine, California-based company said today in a statement. On May 28, Laval, Quebec-based Valeant raised its bid for the first time to $49.4 billion from $45.7 billion.
03/06/2014 | Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion (32.12 billion pounds) takeover bid for Allergan Inc directly to the Botox maker's shareholders in a battle that could last late into the year. The fight escalated when Valeant ally Pershing Square, a hedge fund that owns 9.7 percent of Allergan, called for a meeting to replace the company's board.
03/06/2014 | Advises Stockholders to Take No Action at This Time. Allergan, Inc. issued the following statement regarding the filing by Pershing Square Capital Management, L.P. of preliminary proxy materials with the Securities and Exchange Commission in order to solicit proxies to call a Special Meeting of Allergan’s Stockholders.
28/05/2014 | Galderma will gain full rights to commercialize Restylane, Perlane, Emervel, Sculptra and Dysport for use in aesthetic dermatology in the U.S. and Canada. Galderma Laboratories, L.P. announced today that Nestle S.A., Switzerland, one of Galderma`s shareholders, has entered into an agreement with Valeant Pharmaceuticals International, Inc. and related entities, through which Galderma will become the distributor of several key products in aesthetic dermatology.
12/05/2014 | Allergan Inc. (AGN) rejected Valeant Pharmaceuticals International (VRX) Inc.’s unsolicited takeover proposal, saying the offer “substantially undervalues” the maker of the Botox wrinkle treatment. The bid, which valued Allergan at $45.7 billion in cash and stock when it was announced, creates “significant risks and uncertainties,” the Irvine, California-based company said in a statement today. Allergan expects earnings per share to rise 20 percent to 25 percent in 2015, with double-digit revenue growth, the company said the statement.
30/04/2014 | Irish-headquartered drug manufacturer Shire has been approached once again by Botox giant Allergan about a potential takeover. After its first attempt was rebuffed by the Dublin-based company several months ago, Allergan has planned a fresh approach to $32bn (€23bn) Shire. A combination of Allergan and Shire would create a pharmaceutical giant with a combined market value of nearly $72bn and annual sales of more than $11bn.
29/04/2014 | Allergan has contacted companies including Sanofi and Johnson & Johnson to see if either would be interested in acquiring the Botox maker, said people with knowledge of the matter, as it explores its options after receiving an unsolicited $45.7 billion bid from Valeant Pharmaceuticals.
Allergan is holding early-stage discussions with both companies while it decides whether to seek an alternative to Valeant’s offer, said the people, who asked not to be identified because the matter is private.
22/04/2014 | Valeant Pharmaceuticals is teaming up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion.
Valeant said Monday that it intends to propose a merger with Allergan using a combination of Valeant stock and cash. The transaction size has not been disclosed, but Valeant expects the cash portion of the deal to be at least $15 billion.
16/04/2014 | Initial inquiry forms submitted online may have been accessed in cyber-attack. A leading cosmetic surgery provider has been targeted by a computer hacker who may have accessed details of nearly 500,000 people considering procedures. The Harley Medical Group said it believed the cyber-attack was an attempt to extort money from the company and it had contacted police.
16/04/2014 | Johnson & Johnson has reportedly dropped development of its neurotoxin Purtox, a much-hyped potential rival to Allergan's market leading blockbuster Botox. The move to drop the wrinkle buster is designed to help the healthcare giant hone its focus on its breast aesthetics business, but will result in a small number of job loses in the US, according to media reports.
25/03/2014 | Sinclair IS Pharma plc, the international specialty pharmaceutical company, announces that it has entered into agreements to acquire the global rights to Ellansé™, a combined dermal filler and collagen stimulator product range, through the acquisition of AQTIS Medical BV for an initial consideration of €16.6 million in cash (£13.8 million).
22/03/2014 | Morriston Hospital’s plastic surgery unit has been voted the UK’s best for training the consultants of the future for the third year running. The General Medical Council asked all higher surgical trainees in plastic surgery to score all UK units in a number of areas. These included the level of supervision, level of experience, workload, access to educational resources and overall training and support.
14/02/2014 | Nestlé paid $3.6bn on Wednesday to take full control of Galderma, the dermatology business that revives skin. Nestlé CEO Paul Bulcke will need to do the same at the unit to spur growth. The maker of treatments for acne and psoriasis, Galderma will become part of a new division known as Nestlé Skin Health, with a brand stable ranging from prescription drugs to over-the-counter soaps and sunscreens for skin, hair and nail care.
08/02/2014 | The gel, known as RT001, had promising results from two clinical trials involving a total of 270 people in 2010, helping the company to raise $33 million from investors last year. In 2012, Americans spent almost $11 billion on having their breasts enlarged, their flab flattened and other parts of their body enhanced, according to the American Society for Aesthetic Plastic Surgery. [...] consumers, most of them women, by and large prefer non-invasive work, which accounted for 83 percent of total procedures that year. Essex Woodlands Ventures snapped up about 4 million shares on Thursday for a nearly 25 percent stake in Revance, making the health care investment firm the largest shareholder in the company.
25/01/2014 | Valeant Pharmaceuticals International, Inc. today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International would acquire Solta Medical, Inc. at a price of $2.92 per share in cash, or approximately $250 million in the aggregate.
08/01/2014 | Allergan, Inc., and Medytox, Inc. today announced that they have closed the license agreement which was previously announced on September 25, 2013. Under the terms of the agreement, Allergan will pay Medytox an upfront cash payment of U.S. $65 million within seven business days of closing and Medytox has granted Allergan exclusive rights, worldwide outside of Korea, to develop and, if approved, commercialize certain neurotoxin product candidates currently in development, including a potential liquid-injectable product.
17/12/2013 | Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash. Combination Creates a Global Leader in Aesthetics.Transaction Values Solta at Approximately $250 Million.Transaction Expected to Close in the First Quarter of 2014. Solta`s products include the Thermage CPT, Fraxel repair, Clear + Brilliant, and Liposonix.
08/11/2013 | Merz Pharma today announced that it has purchased the Swiss company Anteis S.A., which is specialized in the development, manufacture and commercialization of biomedical products in the area of aesthetics. This completes a union of two companies that have been working in strong and trustworthy partnership for many years. The acquisition strengthens Merz Aesthetics’ portfolio and reinforces its market position in the field of aesthetic medicine while merging Anteis’ operations into one of the leading providers worldwide.
01/10/2013 | Daewoong Pharmaceutical Co., a major South Korean drug maker, said it has signed a deal with Evolus, a U.S. biotech venture, in a bid to sell its Botox products (marketed as Nabota) in the U.S. and European markets beginning as early as 2016. The deal is designed to start regulatory processes for approval of botulinum toxin type A in the U.S. and European markets, according to Daewoong.
06/09/2013 | Sientra, Inc., a privately-held maker of medical devices including breast implants, successfully defended itself against allegations of strong-arm tactics, anti-competitive behavior and “corporate raiding” by global conglomerate Johnson & Johnson and its operating company, Mentor Worldwide, LLC (Case No. 1402207). After a nearly eight-week trial in the Superior Court of California, a Santa Barbara jury needed fewer than four hours to return a defense verdict in favor of Sientra.
03/08/2013 | Merz Pharma Group today announced that it has entered into a definitive agreement with Swiss dermatology company Neocutis S.A. to acquire the privately held company’s cosmetics, OTC, and Rx skin care business. The acquisition of Neocutis strengthens Merz’s market position in the field of aesthetics and reflects the Company’s strategy to establish itself as a global leader in medical and aesthetic dermatology.
02/08/2013 | ALPHAEON Corporation, announced today that it has acquired an exclusive United States license for the full line of products from Geneva-based TEOXANE Laboratories. Known for high-quality, market-leading products, TEOXANE Laboratories is recognized as an innovator of hyaluronic acid-based wrinkle-filling products currently available in 90 markets outside of the United States.
25/07/2013 | Transform, a cosmetic surgery provider, has launched an internal marketing code of conduct and called on the industry to use unaltered images of patients in its ads. The news comes with the cosmetic surgery industry firmly in the spotlight over its use of advertising.
15/07/2013 | The recent health scandal which saw 20,000 Spanish patients receive defective breast implants has resulted in a rise in demand for trusted, quality medical devices and today, leading manufacturer GC Aesthetics announces the introduction of their British-made implants to Spain. Among the products to be launched by their Nagor brand is Impleo, currently the company's bestselling range in the UK.
13/07/2013 | Dermatologist and founding scientist at SkinCeuticals (L'Oréal) Sheldon Pinnell has died, aged 76. Pinnell is known as the “founding father of topical antioxidants” and is credited for being one of the first scientists to patent a stable form of vitamin C proven to penetrate the skin.
11/07/2013 | A plastic surgeon from Reading who has pledged to clean up the cosmetic surgery industry has expanded his business. Adrian Richards has opened two new centres using local NHS-trained plastic surgeons.
09/07/2013 | Proceeds to Fuel Multiple New Product Launches and Expansion of Distribution. Tria Beauty, Inc. announced the closing of $45.5 million in new equity financing and a new structured debt facility. This latest round of equity financing was led by Bay City Capital, and joined by new investors, AmorePacific Ventures and Athyrium Capital Management.
09/07/2013 | Sales are booming for British medical devices manufacturer Nagor, one of the world’s largest independent suppliers of breast implants as women in the UK shun faulty foreign-made products. In what was dubbed the PIP scandal two years ago, thousands of faulty French-manufactured implants were supplied to women across Europe, including to many in Britain.
04/07/2013 | EternoGen, a Columbia-based biotech startup, has raised $1.065 million in a Series A fundraising round for its collagen product that could compete against aesthetic skin products such as Botox, the company announced Tuesday. EternoGen also expects to raise an additional $500,000 to go toward research and testing of its collagen replenishment therapy.
29/06/2013 | Britain could become a global centre for the production of breast implants as the country's only manufacturer of the silicone product says it is going to double the size of its UK operation within three years. GC Aesthetics will increase its staffing by as much as 40% at its two UK-based breast implant production facilities, at Cumbernauld and Ashby-de-la-Zouche, which currently make more than 75,000 a year under the British Nagor brand - a number expected to grow rapidly as it launches into new markets.
24/06/2013 | Cynosure, Inc., a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the completion of its acquisition of Palomar Medical Technologies, Inc. Cynosure purchased Palomar in a cash and stock transaction valued at approximately $287 million. In the transaction, Cynosure issued approximately six million shares and paid approximately $146 million in cash contributed by both Cynosure and Palomar.
16/05/2013 | The High Court has ordered the winding up a cosmetic surgery clinic which is being sued by a number of women claiming it fitted them with allegedly defective silicone breast implants. The Harley Medical Group (Ireland) Limited, Herbert Place, Dublin petitioned the High Court for a winding up order and appointment of a liquidator on grounds it is insolvent and unable to pay its debts.
08/05/2013 | Chinese healthcare company Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced this week the joint acquisition of the Caesarea, Israel-based Alma Lasers Ltd. with the Pramerica-Fosun Fund. Alma Lasers is an international manufacturer of laser, light-based, radiofrequency and ultrasound products with core R&D capabilities are in the medical and aesthetic device manufacturing field.
29/04/2013 | In the wake of the findings from the Government enquiry into cosmetic surgery published in the last week, the British Association of Aesthetic Plastic Surgeons is first to announce the implementation of one of the report’s major recommendations: for patients to be protected through insurance. The BAAPS was able to work with the world’s leading specialist insurance market, Lloyd’s of London, to create a policy that will safeguard all patients of surgeons who are part of the Association.
15/04/2013 | Leading Cosmetic Surgery Provider MYA and award winning Courthouse Clinics have joined forces to become the UK`s foremost provider of surgical and non-surgical cosmetic treatments. Courthouse Clinics @ MYA will be launched at MYA`s flagship Fenchurch Street clinic and will provide patients with a full range of cosmetic services performed by doctors and top cosmetic surgeons, using only market leading products and equipment including the launch of the new Soprano Ice pain free laser hair removal.
09/04/2013 | Merz Pharma GmbH walked away from an effort to buy Obagi Medical Products Inc., saying it didn’t want to top Valeant Pharmaceuticals International Inc.’s $418 million offer. Merz, a closely held German drugmaker, will look for other acquisition opportunities, the Frankfurt-based company said in a statement today.
04/04/2013 | Botox had better watch out. Another next-gen cosmetic therapy gunning to offer a simpler replacement for the temporary elimination of facial wrinkles is in late-stage development and the biotech developer now has the cash to complete the effort. Six months after Revance Therapeutics agreed to buy back the rights to RT-001--a topical formulation of a new treatment to erase crow's feet--in a $25 million deal designed to resolve a bitter spat with its partners at Medicis, the biotech has rounded up $33 million in Series E cash. That money is being earmarked for an ongoing Phase III study.
21/03/2013 | Canadian drugmaker Valeant Pharmaceuticals International Inc said it would buy Obagi Medical Products Inc for about $344 million to boost its dermatology business.The offer price of $19.75 per share represents a 28 percent premium to Obagi's Tuesday closing price. Obagi's board has unanimously approved the deal, Valeant said in a statement on Wednesday.
18/03/2013 | In a transaction that creates one of the world`s premier aesthetic laser and light-based companies, Cynosure, Inc. (NASDAQ: CYNO) and Palomar Medical Technologies, Inc. (NASDAQ: PMTI) today announced that they have signed a definitive agreement, pursuant to which Cynosure will acquire Palomar in a cash and stock transaction valued at approximately $294 million.
14/03/2013 | Investigators who hunted the late Robert Maxwell’s hidden fortune and who led the search for the missing assets of collapsed claims management company, The Accident Group, have been brought in to probe cosmetic surgery business, Harley Medical Centre Ltd. Paul Stanley, a partner at Begbies Traynor, will look into a number of transactions – including the payment of a dividend of more than £1m in 2010 – at the company, which went into administration in November following claims by thousands of women fitted with faulty breast implants supplied by French firm, Poly Implant Protheses (PIP).
30/01/2013 | Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Sound Surgical Technologies LLC. Under the terms of the agreement, Solta will acquire Louisville, Colorado-based Sound Surgical for $25.5 million in Solta common stock and $5.0 million in cash. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's quarterly earnings within twelve months.
30/01/2013 | CLINIPRO, a Spanish company that manufactures medical-aesthetical devices, announces that the Barcelona Trade Court No. 5 has dictated a resolution, dated January 25th, 2013, fully disregarding the lawsuit promoted by Zeltiq Aesthetics Inc. (Nasdaq: ZLTQ) and Massachusetts General Hospital (MGH) against CLINIPRO, for alleged infringements of patents and disloyal competence acts. The matter has been carried out by the SOL MUNTAÑOLA & ASOCIADOS office, which CLINIPRO put in charge of the legal management.
08/01/2013 | Medical and cosmetic healthcare firm Allergan, best known as the maker of Botox, has boosted its European comms capabilities with two important hires. Allergan has poached Julia Kendrick and Bahar Turkoglu from Chandler Chicco Agency (CCA), the firm’s longstanding adviser in the UK and Europe.
07/01/2013 | Research and Markets has announced the addition of the "U.S. Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices Market" report to their offering. In 2012, the U.S. market for cosmetic surgery, facial aesthetics and medical laser devices was valued over $3 billion, an increase of almost 10% from the previous year.
02/12/2012 | A young mother has been stabbed to death and her husband arrested following a row over cash.
Beauty Therapist (and Territory Manager for Obagi Medical Products/Health Xchange Pharmacy) Janeé Parsons , 31, was discovered fatally injured after neighbours heard screams and called 999. Her husband, heating engineer Andrew, 38, was arrested on suspicion of murder at their family home.
01/12/2012 | The charter, called ‘Clear’, is the first of its kind to be launched by a provider in the UK and features five clear commitments and 15 patient promises. Britain’s longest established cosmetic surgery provider Transform, has today launched an extensive patient care charter with the help of its first forward-thinking panel.
18/11/2012 | Thousands of British women fitted with faulty breast implants face further agony after a clinic at the centre of the scandal deliberately went into administration to avoid a possible multi-million-pound legal payout. The Harley Medical Centre faced legal claims from 1,700 women who suffered pain and distress after being fitted with defective PIP implants. But last week, the cosmetic surgery chain appointed administrators after its management complained that legal action could put the firm out of business.
16/11/2012 | Allergan Inc., the Botox maker weighing the sale of its obesity unit, will expand the range of its skin care products by agreeing to purchase a unit from SkinMedica Inc. for $350 million. SkinMedica’s products include a prescription treatment for reducing female facial hair and lotions to reduce the appearance of wrinkles.
15/11/2012 | A federal injunction filed March 9 against Merz Aesthetics for violating California`s Uniform Trade Secrets Act has been lifted. The decision will allow the company to promote and sell its dermal fillers, Belotero Balance® and Radiesse®, without restriction. However, the company`s new botulinum toxin product, Xeomin®, remains unavailable for sample, purchase or sales in the facial aesthetics market until Jan. 9.
09/11/2012 | The wounded returned from the first great armed conflict of the 20th century lucky to be alive but unrecognisable to their loved ones. These pictures reveal the ugly reality of war – the disfigurements of thousands of young men who travelled to Sidcup to be treated by Dr Harold Gillies, the pioneer of plastic surgery.
09/11/2012 | Hybrid Energy Technology, a breakthrough concept, delivers Dermal Volumizing, reduction of wrinkles and mini facelift effects without surgery, discomfort or downtime. In clinical evaluation Hybrid Energy demonstrated significant dermal refilling, and reduction of wrinkles as well as improvement in skin texture, minimizing of pores and volume increase. Hybrid Energy Technology is available through Surgen, a cutting-edge platform which also integrates Pollogen’s patented TriFractional technology for advanced skin resurfacing.
05/11/2012 | Syneron Medical Ltd. , the leading global aesthetic device company, announced to a group of international media its new activities and enhanced global commitment to developing the non-invasive body shaping market, one of the fastest growing segments in the global aesthetic medical device market. The press conference took place at the Academy of Medical Sciences in London, just prior to the opening of the BODY Conference and Exhibition , which took place in London on November 3-4, 2012 and for which Syneron was the main sponsor.
26/10/2012 | A private health clinic in Newport which carried out cosmetic surgery and gastric band operations went into administration yesterday with the loss of 25 jobs. Nucleus Healthcare Limited, trading as Celtic Springs Clinic said numerous attempts to solve cashflow pressures were unsuccessful. A special helpline 01633 815900 has been set up for patients who were due to have surgery at the clinic on Celtic Springs Business Park.
17/10/2012 | Aesthetics International, the plastic and cosmetic surgery clinic founded by Dr Jaffer Khan, has announced the launch of its Aesthetics International charity foundation. Details of the charity fund were shared with guests at an invite-only event held at The Capital Club in Dubai, during which Dr Mohammad Jawad (a Plastic, Reconstructive & Burns surgeon, practicing in the UK and at Aesthetics International in Dubai) gave a private screening of his Oscar-winning documentary Saving Face.
09/10/2012 | Medicis Pharmaceutical and Revance Therapeutics have come up with a deal to resolve an apparently bitter development dispute. RTT News reports that Revance will get back the rights licensed to Medicis--recently sold to Valeant ($VRX)--on two next-gen botox therapies in exchange for $7 million in cash and $18 million in milestones. Medicis keeps its equity in Revance and the two companies will drop litigation.
22/09/2012 | The British Association of Aesthetic Plastic Surgeons, the not-for-profit organisation established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit, today announced the appointment of London-based consultant plastic surgeon Rajiv Grover to the role of President.
19/09/2012 | Merz Pharmaceuticals/Merz Aesthetics will see an increased presence in the aesthetics market with Xeomin and Belotero once Allergan’s injunction is lifted, plastic surgeons told BioPharm Insight. Merz’s Xeomin will fare well against Allergan’s Botox thanks to an expected lower price tag, and Belotero will establish a niche in the dermal fillers market, they agreed.
08/09/2012 | Dallas plastic surgeon Rod J. Rohrich, along with colleagues, address ways to promote adoption of evidence based plastic surgery. Goals include production of higher-level evidence, integration of evidence into training, and application of evidence based plastic surgery research to clinical practice.
04/09/2012 | (Reuters) - Valeant Pharmaceuticals International Inc agreed on Monday to buy Medicis Pharmaceutical Corp for $2.6 billion in cash, in a deal that will add Botox competitor Dysport and other skin care drugs to its portfolio.
01/09/2012 | Ellman International, a developer of radiofrequency technology for precision surgical and aesthetic procedures, has announced its acquisition of Sandstone Medical Technologies, developer of aesthetic laser and intense pulsed light technologies.
08/08/2012 | In the July 2012 issue of Aesthetic Surgery Journal, board-certified plastic surgeon in Atlanta, Dr. Joseph G. Bauer, and attorney in Atlanta, Richard M. Escoffery, Esq, discuss the options and challenges in monitoring a physician’s or a medical practice’s online reputation.
02/08/2012 | Babtac, the British Association of Beauty Therapy and Cosmetology, has signed a deal with Program E>O to make the IPL manufacturer its first corporate member supplier. Program E>O offers its IPL hair removal treatment system to salons to rent. As part of the partnership, Babtac will promote the machine to its member salons, while Program E>O IPL will raise awareness about Babtac’s courses and membership when liasing with its own salon accounts and potential stockists.
19/07/2012 | The cosmetic surgery firm that fitted 1,100 Irish women with below-grade silicone breast implants went into the red last year. New figures show that the Dublin-based Harley Medical Group Ireland Ltd recorded a pre-tax loss last year of €92,450, following a pre-tax profit of €232,642 in 2010.
15/07/2012 | Leading doctors are calling on the government to legally protect the title "surgeon" so the public can be clear about practitioners' qualifications. A Royal College of Surgeons (RCS) poll of 2,000 people found 95% expect someone using the title "surgeon" to be medically qualified.
12/07/2012 | A major stake in one of Britain’s biggest providers of the controversial PIP breast implants is poised to change hands following a review of its ownership. General Healthcare Group (GHG), which trades under the name BMI Medical, is to explore options for its 42% shareholding in Transform Cosmetic Surgery Group.
21/06/2012 | Dr. Monica Elman and Dr. Eli Raviv to Administer New Course for Medical Practitioners. A new course, approved by the Israel Ministry of Health, is available to physicians for the study of aesthetic treatments, utilizing the human cadaver.
31/05/2012 | The Habia Skills Academy is launching advanced courses for trainers in laser and light-based hair removal this summer.
11/05/2012 | L’Oreal SA (OR)’s effort to register trademarks that sound similar to Botox, a wrinkle treatment made by Allergan Inc. (AGN), was rejected by the top European Union court. The EU Court of Justice backed the earlier refusals by the EU trademark office for L’Oreal to own the rights to the words “botolist” and “botocyl” for cosmetic products.
06/05/2012 | A cosmetic surgeon who has treated thousands of women at his Harley Street clinic faces being struck off over claims he offered banned financial incentives for patients to undergo treatment. Dr Aamer Khan, who counts TV presenters, actresses and models among his clients, is accused of breaching strict marketing rules for cosmetic surgeons.
01/05/2012 | A UK University launches a new degree course for surgeons to improve the safety of cosmetic procedures like facelifts and boob jobs. Anglia Ruskin University says it hopes the qualification will put an end to "have-a-go surgeons" and deter Brits from traveling abroad for surgery. But plastic surgeons say the new MSc course is an unnecessary addition.
07/04/2012 | Discretionary procedures and services are an important source of income for many medical practices – including plastic surgery - and marketing is a key tool for bringing in new business. While the options available for online marketing are myriad, plastic surgeons should be wary of reaching out via coupons offered by social media sites - they could be getting more than they bargained for, according to The Doctors Company (TDC).
13/03/2012 | Allergan Inc. said a U.S. district court issued a permanent injunction against a maker of a Botox alternative that was accused of violating California's Uniform Trade Secrets Act. The injunction prohibits Merz Pharmaceuticals and Merz Aesthetics from selling Xeomin for 10 months.
07/03/2012 | Allergan Inc., the maker of Botox injections for frown lines, won a court order blocking Merz Pharma GmbH from selling a rival cosmetic product after Allergan claimed its trade secrets were stolen. U.S. District Judge Andrew J. Guilford in Santa Ana, California, yesterday issued an injunction against Merz following a trial without a jury.
28/02/2012 | The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) and Eyemaginations, Inc. recently entered into an agreement regarding patient education. Under the agreement, the AAFPRS will be featuring a series of exciting new animations on its website to provide compelling, medically accurate animations on a variety of the main procedures that facial plastic surgeons perform.
09/02/2012 | YOKNEAM, ISRAEL--(Marketwire - Feb 8, 2012) - Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that is has signed a definitive agreement to acquire Ultrashape Ltd. ("Ultrashape"), a leading developer, manufacturer and marketer of innovative non-invasive technologies for fat cell destruction and body sculpting.
19/10/2011 | The British Association of Aesthetic Plastic Surgeons have spoken out against the British Governments proposal to tax all plastic surgeries carried out for cosmetic reasons
19/10/2011 | “No downtime.” “Moderate redness.” “Minimal bruising.” When it comes to the many light- and energy-based devices used for aesthetic procedures from hair removal to body contouring, what do these claims really mean?